NCT05680740View on ClinicalTrials.gov

A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

December 27, 2022

Primary Completion Date

May 18, 2023

Study Completion Date

May 25, 2023

Conditions
Psoriasis
Interventions
DRUG

VTAMA® (tapinarof) Cream 1%

VTAMA® (tapinarof) Cream 1% applied topically once daily

Trial Locations (7)

33063

Dermavant Investigative Site, Margate

33431

Dermavant Investigative Site, Boca Raton

46168

Dermavant Investigative Site, Plainfield

72916

Dermavant Investigative Site, Fort Smith

77004

Dermavant Investigative Site, Houston

77598

Dermavant Investigative Site, Webster

90045

Dermavant Investigative Site, Los Angeles

All Listed Sponsors
lead

Organon and Co

INDUSTRY